Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1974 Jun;27(6):485–489. doi: 10.1136/jcp.27.6.485

Coagulation fibrinolysis in sickle-cell disease

P A Gordon 1, G R Breeze 1, J R Mann 1, J Stuart 1
PMCID: PMC478160  PMID: 4412492

Abstract

A study of fibrinolytic activity in sickle-cell patients during asymptomatic periods has shown a normal fibrinolytic response to exercise and local heat to the arm. During vasoocclusive crises there was no significant decrease in fibrinolytic activity. These results contrast with earlier reports of decreased fibrinolysis during crisis and a suggestion that fibrinolytic activators might be of value in preventing vasoocclusive episodes.

Patients in painful crisis showed a significant rise in fibrinogen concentration and fall in platelet count. The former may contribute to localized vascular sludging by increasing whole-blood viscosity, while the latter probably results from local trapping of platelets in areas of sickling or from subsequent splenic sequestration of damaged platelets. There was no evidence of disseminated, as opposed to localized, intravascular coagulation during crisis.

Full text

PDF
485

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
  3. Cash J. D., Allan A. G. Effect of mental stress on the fibrinolytic reactivity to exercise. Br Med J. 1967 May 27;2(5551):545–548. doi: 10.1136/bmj.2.5551.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cash J. D. Effect of moderate exercise on the fibrinolytic system in normal young men and women. Br Med J. 1966 Aug 27;2(5512):502–506. doi: 10.1136/bmj.2.5512.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Das P. C., Allan A. G., Woodfield D. G., Cash J. D. Fibrin degradation products in sera of normal subjects. Br Med J. 1967 Dec 23;4(5581):718–720. doi: 10.1136/bmj.4.5581.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dodman B., Cunliffe W. J., Roberts B. E., Buchan C. W. Effects of changes in temperature (local and central) on plasma fibrinolytic activity. J Clin Pathol. 1973 Apr;26(4):248–249. doi: 10.1136/jcp.26.4.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FEARNLEY G. R., BALMFORTH G., FEARNLEY E. Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci. 1957 Nov;16(4):645–650. [PubMed] [Google Scholar]
  8. FEARNLEY G. R. MEASUREMENT OF SPONTANEOUS FIBRINOLYTIC ACTIVITY. J Clin Pathol. 1964 May;17:307–309. doi: 10.1136/jcp.17.3.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gilles H. M., Reid H. A., Odutola A., Ransome-Kuti O., Ransome-Kuti S., Lesi F. Arvin treatment for sickle-cell crisis. Lancet. 1968 Sep 7;2(7567):542–543. doi: 10.1016/s0140-6736(68)92411-2. [DOI] [PubMed] [Google Scholar]
  10. Green D., Kwaan HC RUIZ G. Impaired fibrinolysis in sickle cell disease. Relation to crisis and infection. Thromb Diath Haemorrh. 1970 Oct 31;24(1):10–16. [PubMed] [Google Scholar]
  11. Haddock D. R., Bonotey-Ahulu F. I., Janosi M., Ankra-Badu G., Reid H. A. Thrombosis in sickle-cell pain crises? Controlled trial of ancrod (Arvin) in young adults. J Trop Med Hyg. 1973 Nov;76(11):274–278. [PubMed] [Google Scholar]
  12. Haut M. J., Cowan D. H., Harris J. W. Platelet function and survival in sickle cell disease. J Lab Clin Med. 1973 Jul;82(1):44–53. [PubMed] [Google Scholar]
  13. Hutchinson R. M., Merrick M. V., White J. M. Fat embolism in sickle cell disease. J Clin Pathol. 1973 Aug;26(8):620–622. doi: 10.1136/jcp.26.8.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ihenacho H. N., Fletcher D. J., Breeze G. R., Stuart J. Consumption coagulopathy in congenital heart-disease. Lancet. 1973 Feb 3;1(7797):231–234. doi: 10.1016/s0140-6736(73)90069-x. [DOI] [PubMed] [Google Scholar]
  15. Jones S. R., Binder R. A., Donowho E. M., Jr Sudden death in sickle-cell trait. N Engl J Med. 1970 Feb 5;282(6):323–325. doi: 10.1056/NEJM197002052820607. [DOI] [PubMed] [Google Scholar]
  16. Mahmood A. Fibrinolytic activity and sickle-cell crises. Br Med J. 1969 Jan 4;1(5635):52–53. doi: 10.1136/bmj.1.5635.52-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mahmood A., Macintosh D. M., Shaper A. G. Fibrinolytic activity in the clinical crisis of sickle-cell anaemia. Br Med J. 1967 Sep 9;3(5566):653–654. doi: 10.1136/bmj.3.5566.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mann J. R., Deeble T. J., Breeze G. R., Stuart J. Ancrod in sickle-cell crisis. Lancet. 1972 Apr 29;1(7757):934–937. doi: 10.1016/s0140-6736(72)91498-5. [DOI] [PubMed] [Google Scholar]
  19. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  20. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  21. REMMERT L. F., COHEN P. P. Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem. 1949 Nov;181(1):431–448. [PubMed] [Google Scholar]
  22. Replogle R. L., Meiselman H. J., Merrill E. W. Clinical implications of blood rheology studies. Circulation. 1967 Jul;36(1):148–160. doi: 10.1161/01.cir.36.1.148. [DOI] [PubMed] [Google Scholar]
  23. SALVAGGIO J. E., ARNOLD C. A., BANOV C. H. Long-term anti-coagulation in sickle-cell disease. A clinical study. N Engl J Med. 1963 Jul 25;269:182–186. doi: 10.1056/NEJM196307252690403. [DOI] [PubMed] [Google Scholar]
  24. WALTERS J. H. Vascular occlusion in sickle-cell disease. Proc R Soc Med. 1958 Aug;51(8):646–648. [PubMed] [Google Scholar]
  25. WELLS R. E., Jr, GAWRONSKI T. H., COX P. J., PERERA R. D. INFLUENCE OF FIBRINOGEN ON FLOW PROPERTIES OF ERYTHROCYTE SUSPENSIONS. Am J Physiol. 1964 Nov;207:1035–1040. doi: 10.1152/ajplegacy.1964.207.5.1035. [DOI] [PubMed] [Google Scholar]
  26. Weaver J. P., Evans A., Walder D. N. The effect of increased fibrinogen content on the viscosity of blood. Clin Sci. 1969 Feb;36(1):1–10. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES